State NC
Clinical Trials in North Carolina
Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in North Carolina
NCT03587272 Phase 2
Recruiting
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children ...
Condition
Sickle Cell Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Robert Nickel
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT05440929 N/A
Recruiting
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a...
Condition
Metastatic Breast Cancer
Enrollment
15 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C
NCT05283720 Phase 2
Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneou...
Condition
Non-Hodgkin Lymphoma
Enrollment
496 pts
Location
United States, China, Czechia
Sponsor
Genmab
NCT05156983 Phase 3
Recruiting
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Nee...
Condition
Coagulation Disorder
Enrollment
328 pts
Location
United States, Argentina, Austria
Sponsor
Takeda
NCT07396766 N/A
Recruiting
Dissemination of BREASTChoice AIM1-B
Condition
Breast Cancer
Enrollment
20 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C
NCT05396456 N/A
Recruiting
Autologous Muscle Fiber Fragment Injections
Condition
Fecal Incontinence
Enrollment
10 pts
Location
United States
Sponsor
Wake Forest University Health
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
NCT05618353 Phase 4
Recruiting
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Condition
Coronary Artery Disease
Enrollment
700 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07096674 Phase 2
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopa...
Condition
Narcolepsy Type 1
Enrollment
90 pts
Location
United States
Sponsor
Centessa Pharmaceuticals (UK)
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
NCT07298356 N/A
Recruiting
Automated Applanation Tonometry - Updated
Condition
Glaucoma
Enrollment
200 pts
Location
United States
Sponsor
Duke University
NCT06034002 Phase 1
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination W...
Condition
Myeloproliferative Neoplasms
Enrollment
230 pts
Location
United States
Sponsor
Incyte Corporation
NCT06465810 N/A
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Condition
Transthyretin Amyloidosis
Enrollment
1,850 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT06422923 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral...
Condition
Epilepsy, Temporal Lobe
Enrollment
10 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Condition
High Grade Glioma
Enrollment
60 pts
Location
United States, Australia, Canada
Sponsor
Rigel Pharmaceuticals
NCT05566769 N/A
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMO...
Condition
Neuromyelitis Optica
Enrollment
103 pts
Location
United States, France, Germany
Sponsor
Ad scientiam
NCT04861818 N/A
Recruiting
The Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young...
Condition
Aerobic Exercise
Enrollment
80 pts
Location
United States
Sponsor
University of North Carolina,
NCT05104983 Phase 2
Recruiting
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Condition
Tuberous Sclerosis Complex
Enrollment
64 pts
Location
United States
Sponsor
Darcy Krueger
NCT06188923 Phase 2
Recruiting
A New Intervention to Improve Function in Veterans With Anxiety and Depression
Condition
Anxiety and Depression
Enrollment
84 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT04396808 N/A
Recruiting
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men Wit...
Condition
Prostate Cancer
Enrollment
900 pts
Location
United States
Sponsor
University of Michigan Rogel C